The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Renogrit Patanjali’s herbal formulation is featured among the top 100 research papers of 2024 in Scientific Reports Here’s ...

In the letter, President Guskiewicz detailed the 1965 discovery of cisplatin, a chemotherapy drug created by MSU researchers.

Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

The addition of concurrent cisplatin chemotherapy to adjuvant radiation therapy (CRT), versus RT alone, couldn't move the ...

Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer cases and is the sixth most common cause of cancer death worldwide. Targeting cancer stem cells offers a ...

Adjuvant CRT did not improve outcomes over adjuvant RT in patients with intermediate-risk, early-stage cervical cancer after radical hysterectomy.

In metastatic urothelial carcinoma, Padcev plus Keytruda elicited responses in the first-line setting, with Padcev showing ...

The second group received no neoadjuvant therapy prior to surgery, followed by either standard of care radiotherapy with cisplatin (100mg/m 2 IV Q3W for 3 cycles) as adjuvant therapy following ...

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for ...